LOS
ANGELES, Jan. 30, 2025 /PRNewswire/ -- The DJS
Law Group announces that it is investigating claims on behalf
of investors of CARGO Therapeutics, Inc. ("CARGO" or "the
Company") (NASDAQ: CRGX) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on
whether the Company issued misleading statements and/or failed to
disclose information pertinent to investors. A CARGO press release
dated January 29, 2025, indicates
that it will discontinue FIRCE-1, a Phase 2 clinical study of
firi-cel, its drug candidate for the treatment of large B-cell
lymphoma (LBCL). The Company's decision is based on the number of
adverse events suffered by patients, combined with the fact that
"the data generated so far does not meet our expectations of a
competitive benefit-risk profile for patients in the context of
available treatment options. Therefore, we believe it is in the
best interest of both patients and shareholders to discontinue the
study,"
If you are a shareholder who suffered a loss, contact us to
participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is
to enhance investor return through balanced counseling and
aggressive advocacy. We specialize in securities class actions,
corporate governance litigation, and domestic/international M&A
appraisals. Our clients are some of the largest and most
sophisticated hedge funds and alternative asset managers in the
world. The litigation claims of our clients are extraordinarily
valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cargo-therapeutics-inc-investigated-for-securities-fraud-violations---contact-the-djs-law-group-to-discuss-your-rights---crgx-302364689.html
SOURCE DJS Law Group LLP
